Related Experiment Videos
Pediatric reference intervals for 27 routine chemistry analytes in healthy children and adolescents on the Roche
Benjamin Jung1,2, Mehdi Hooshmandi3, Lusia Sepiashvili1,2
1Department of Pediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada.
Insights
This study establishes crucial pediatric reference intervals for 27 routine chemistry tests on the Roche cobas pro platform. These age- and sex-specific reference intervals (RIs) are vital for accurate pediatric diagnosis and monitoring.
Area of Science:
- Clinical Chemistry
- Pediatric Laboratory Medicine
- Reference Interval Determination
Background:
- Accurate interpretation of pediatric lab results necessitates age- and sex-specific reference intervals (RIs).
- Establishing pediatric RIs is challenging due to rapid physiological changes during growth and development.
- Pediatric RIs for the widely used Roche cobas pro platform were previously unavailable.
Purpose of the Study:
- To establish pediatric reference intervals (RIs) for 27 routine chemistry analytes on the Roche cobas pro c503 analyzer.
- To address the critical gap in pediatric laboratory medicine regarding platform-specific RIs.
- To provide clinically relevant data for accurate diagnosis and monitoring in pediatric care.
Main Methods:
- The Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) study analyzed serum samples from 300-500 healthy children and adolescents per analyte.
- Analytical performance was verified for imprecision, linearity, and method comparison.
- Reference intervals were determined using nonparametric methods following CLSI guidelines.
Main Results:
- All 27 routine chemistry assays met analytical performance criteria.
- Age-specific partitions were required for 23 analytes, and sex-specific partitions for some markers, especially in adolescents.
- Electrolytes showed stable RIs, while growth, bone, liver, and muscle-related analytes exhibited significant age- and sex-related variations.
Conclusions:
- This study presents the first comprehensive pediatric reference intervals for 27 routine chemistry analytes on the Roche cobas pro platform.
- These platform-specific RIs fill a critical need in pediatric laboratory medicine.
- The established RIs will support improved diagnostic accuracy and patient monitoring in pediatric care.
Objectives:
Accurate interpretation of pediatric laboratory test results requires robust age- and sex-specific reference intervals (RIs). Undertaking studies to establish RIs across the pediatric age range is particularly challenging due to rapid physiological changes during growth and development. While the Roche cobas pro platform is increasingly adopted in clinical laboratories, pediatric-specific RIs for routine chemistry analytes on this system have not yet been established.
Methods:
This Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER) study aimed to establish pediatric RIs for 27 routine chemistry analytes on the Roche cobas pro c503 analyzer. Analytical performance verification included imprecision, linearity, and method comparison studies. Serum samples from 300 to 500 healthy children and adolescents (birth to <19 years) per analyte were analyzed. Reference intervals were established using nonparametric methods in accordance with CLSI guidelines.
Results:
All assays met predefined analytical performance criteria, with imprecision <4 %, acceptable linearity across the analytical measuring range, and strong agreement with comparator platforms (r=0.93-0.99). Age-specific partitions were required for 23 of 27 analytes, while sex-specific partitions were necessary for select markers, particularly during adolescence. Electrolytes such as sodium and chloride showed stable RIs across all ages, whereas analytes influenced by growth, bone metabolism, liver function, and muscle mass demonstrated marked age- and sex-related variation.
Conclusions:
This study establishes the first comprehensive set of pediatric reference intervals for 27 routine chemistry analytes on the Roche cobas pro platform. These data address a critical gap in pediatric laboratory medicine and provide clinically relevant, platform-specific RIs to support accurate diagnosis and monitoring in pediatric care.
Related Concept Videos
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution